EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Protein glycosylation in lung cancer from a mass spectrometry perspective

Mirjam Balbisi iD, Simon Sugár, Lilla Turiák iD

Mass Spectrometry Reviews · 2026-05 · 45 (3) · 455-475

DOI: 10.1002/mas.21882 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mass Spectrometry Reviews, online erschienen am 04.04.2024. Verfasst von Mirjam Balbisi und 2 weiteren Autor:innen. Beteiligte Einrichtung: MTA-TTK Lendület (Momentum) Glycan Biomarker Research Group, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary. Hauptthemen laut MEDLINE: Lung Neoplasms, Mass Spectrometry, Glycoproteins. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: János Bolyai Research Scholarship of the Hungarian Academy of Sciences, National Research, Development, and Innovation Fund of Hungary, Lendület (Momentum) Program of the Hungarian Academy of Sciences (HAS, MTA).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is a severe disease for which better diagnostic and therapeutic approaches are urgently needed. Increasing evidence implies that aberrant protein glycosylation plays a crucial role in the pathogenesis and progression of lung cancer. Differences in glycosylation patterns have been previously observed between healthy and cancerous samples as well as between different lung cancer subtypes, which suggests untapped diagnostic potential. In addition, understanding the changes mediated by glycosylation may shed light on possible novel therapeutic targets and personalized treatment strategies for lung cancer patients. Mass spectrometry based glycomics and glycoproteomics have emerged as powerful tools for in‐depth characterization of changes in protein glycosylation, providing valuable insights into the molecular basis of lung cancer. This paper reviews the literature on the analysis of protein glycosylation in lung cancer using mass spectrometry, which is dominated by manuscripts published over the past 5 years. Studies analyzing N ‐glycosylation, O ‐glycosylation, and glycosaminoglycan patterns in tissue, serum, plasma, and rare biological samples of lung cancer patients are highlighted. The current knowledge on the potential utility of glycan and glycoprotein biomarkers is also discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsMass SpectrometryGlycoproteinsHumansGlycosylationBiomarkers, TumorProteomicsGlycomicsPolysaccharidesGlycosaminoglycansAnimals

Stichwörter der Autor:innen

N‐glycosylationO‐glycosylationglycosaminoglycanlung cancermass spectrometry

Substanzen

Biomarkers, TumorGlycoproteinsPolysaccharidesGlycosaminoglycans

Autor:innen und Institutionen

  • MTA-TTK Lendület (Momentum) Glycan Biomarker Research Group, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.
  • Semmelweis University Doctoral School, Budapest, Hungary.

ORCID-Profile: Mirjam Balbisi, Lilla Turiák

Förderung

  • János Bolyai Research Scholarship of the Hungarian Academy of Sciences
  • National Research, Development, and Innovation Fund of Hungary
  • Lendület (Momentum) Program of the Hungarian Academy of Sciences (HAS, MTA)

Zitieren

APA

Balbisi, M., Sugár, S., & Turiák, L. (2026). Protein glycosylation in lung cancer from a mass spectrometry perspective. Mass Spectrometry Reviews, 45(3), 455-475. https://doi.org/10.1002/mas.21882

Vancouver

Balbisi M, Sugár S, Turiák L. Protein glycosylation in lung cancer from a mass spectrometry perspective. Mass Spectrometry Reviews. 2026;45(3):455-475. doi:10.1002/mas.21882

BibTeX
@article{Balbisi2026,
  author = {Balbisi, Mirjam and Sugár, Simon and Turiák, Lilla},
  title = {Protein glycosylation in lung cancer from a mass spectrometry perspective},
  journal = {Mass Spectrometry Reviews},
  year = {2026},
  volume = {45},
  number = {3},
  pages = {455--475},
  doi = {10.1002/mas.21882}
}
Kostenlos starten →